De novo chromophobe renal cell carcinoma in the graft three decades after renal transplantation in a patient with a history of three renal transplants

Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
Mohamed H ZahranBedeir Ali-El-Dein

Abstract

De novo renal allograft tumors were reported sporadically. Most of them were small, low-grade, and papillary renal cell carcinoma (RCC) type. A 46-year-old male presented with hematuria three decades after the first transplant. The patient had a history of three renal transplants. A tumor (12 cm × 13 cm) was diagnosed in the nonfunctioning first transplanted kidney. Radical nephrectomy of the graft harboring the tumor with preservation of the adjacent functioning graft was done and identified to be chromophobe RCC. After two-year follow-up, the patients had a perfect graft function with no evidence of oncological failure. We suggest that allograft tumor be considered in patient evaluation for hematuria. Regular follow-up imaging of transplanted kidney is mandatory even after graft failure for early detection of graft tumors.

References

Feb 26, 1998·International Journal of Urology : Official Journal of the Japanese Urological Association·K I ParkT Tomoyoshi
Jun 16, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Andres J GrecoBernard S Kaplan
Nov 24, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A BaramaP Daloze
Jul 21, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A C WebsterJ R Chapman
Sep 11, 2012·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·X TillouJ Petit
Feb 1, 2013·American Journal of Nephrology·Ludovic ViartXavier Tillou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Archivos españoles de urología
José Emilio Hernández SánchezAngel Silmi Moyano
Case Reports in Transplantation
Abdullah AlharbiKhaled O Alsaad
Archivos españoles de urología
R González-LópezF J Burgos Revilla
Actas urologicas españolas
I Gómez GarcíaA Escudero Barrilero
Actas urologicas españolas
R González-LópezC González-Enguita
© 2021 Meta ULC. All rights reserved